Licensed indications 2,3 2,3 Subcutaneous semaglutide (Wegovy) and tirzepatide (Mounjaro) are indicated as adjuncts to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial BMI of: 30 kg/m 2 (obesity), or 27 kg/m 2 to 2 days away, administer as soon as possible
Tips for Taking Doxycycline While on a GLP-1 Program If your provider has prescribed doxycycline while you are on a weight loss program, there are several steps you can take to minimize discomfort
The peptide has regulatory approval for some sexual dysfunctions, demonstrating it can be safely utilized under medical supervision
Retatrutide also remains investigational, with ClinicalTrials.gov listing active or recently updated Phase 3 research records as of May 2026
With their expert guidance and supportive approach, you can achieve your weight loss goals and feel better, healthier, and more confident in the process